PNC Financial Services Group
NGNE icon

PNC Financial Services Group’s Neurogene NGNE Stock Holding History

PNC Financial Services Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Sell
4,501
-546
-11% -$15K ﹤0.01% 2698
2026
Q1 		$102K Sell
5,047
-77
-2% -$1.49K ﹤0.01% 2805
2025
Q4 		$106K Buy
5,124
+69
+1% +$1.72K ﹤0.01% 2769
2025
Q3 		$87.6K Buy
5,055
+1,000
+25% +$20.1K ﹤0.01% 2896
2025
Q2 		$60.6K Buy
4,055
+1,232
+44% +$19.3K ﹤0.01% 3006
2025
Q1 		$33.1K Sell
2,823
-303
-10% -$5.26K ﹤0.01% 3311
2024
Q4 		$71.5K Buy
+3,126
New +$116K ﹤0.01% 2895

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

PNC Financial Services Group's NGNE Position: Q2 2026 in Review

PNC Financial Services Group reduced its Neurogene (NGNE) stake by 11% in Q2 2026, selling an estimated $15K and leaving 4,501 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

PNC Financial Services Group first reported a position in NGNE in Q4 2024 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • PNC Financial Services Group held 4,501 shares of Neurogene worth $142K as of Q2 2026.
  • PNC Financial Services Group sold 546 Neurogene shares in Q2 2026, an estimated $15K.
  • Neurogene made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2698 holding.
  • PNC Financial Services Group first reported a position in Neurogene in Q4 2024 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.